Performance status
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
In medicine (oncology and other fields), performance status is an attempt to quantify cancer patients' general wellbeing. This measure is used to determine whether they can receive chemotherapy, whether dose adjustment is necessary, and as a measure for the required intensity of palliative care. It is also used in oncological randomized controlled trials as a measure of quality of life.
Scoring systems
There are various scoring systems. The most generally used are the Karnofsky score and the Zubrod score, the latter being used in publications by the WHO. For children, the Lansky score is used.
Parallel scoring systems include the Global Assessment of Functioning (GAF) score, which has been incorporated as the fifth axis of the Diagnostic and Statistical Manual (DSM) of psychiatry.
Karnofsky scoring
The Karnofsky score runs from 100 to 0, where 100 is "perfect" health and 0 is death. Although the score has been described with intervals of 10, a practitioner may choose decimals if he or she feels a patient's situation holds somewhere between two marks. It is named after Dr David A. Karnofsky, who described the scale with Dr Joseph H. Burchenal in 1949.
- 100% - normal, no complaints, no signs of disease
- 90% - capable of normal activity, few symptoms or signs of disease
- 80% - normal activity with some difficulty, some symptoms or signs
- 70% - caring for self, not capable of normal activity or work
- 60% - requiring some help, can take care of most personal requirements
- 50% - requires help often, requires frequent medical care
- 40% - disabled, requires special care and help
- 30% - severely disabled, hospital admission indicated but no risk of death
- 20% - very ill, urgently requiring admission, requires supportive measures or treatment
- 10% - moribund, rapidly progressive fatal disease processes
- 0% - death.
ECOG/WHO/Zubrod score
The ECOG score (published by Oken et al in 1982), also called the WHO or Zubrod score (after C. Gordon Zubrod), runs from 0 to 5, with 0 denoting perfect health and 5 death:
- 0 - Asymptomatic
- 1 - Symptomatic but completely ambulant
- 2 - Symptomatic, <50% in bed during the day
- 3 - Symptomatic, >50% in bed, but not bedbound
- 4 - Bedbound
- 5 - Death
Lansky score
Children, who might have more trouble expressing their experienced quality of life, require a somewhat more observational scoring system suggested and validated by Lansky et al in 1987:
- 100 - fully active, normal
- 90 - minor restrictions in strenuous physical activity
- 80 - active, but tired more quickly
- 70 - greater restriction of play and less time spent in play activity
- 60 - up and around, but active play minimal; keeps busy by being involved in quieter activities
- 50 - lying around much of the day, but gets dressed; no active playing participates in all quiet play and activities
- 40 - mainly in bed; participates in quiet activities
- 30 - bedbound; needing assistance even for quiet play
- 20 - sleeping often; play entirely limited to very passive activities
- 10 - doesn't play; does not get out of bed
- 0 - unresponsive
References
- Karnofsky DA, Burchenal JH. The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod CM (Ed), "Evaluation of Chemotherapeutic Agents." Columbia Univ Press, 1949:196.
- Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR. The measurement of performance in childhood cancer patients. Cancer 1987;60:1651-6. PMID 3621134.
- Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655. PMID 7165009.
External links
- Performance status calculator (Food and Drug Administration (FDA))
- A table with the Karnofsky Performance Status.
- Karnofsky and Zubrod/WHO score
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
